Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 1 - 8
Code: NCT06188741
Phase 2, Recruiting
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
for
Ovarian Neoplasms, Breast Neoplasms
Location: Boston MA, Lake Success NY, Morristown NJ, Toronto,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT04641247
Phase 2, Recruiting
Using Non-invasive Brain Stimulation to Treat Word Finding Difficulty in Chronic Traumatic Brain Injury
for
Traumatic Brain Injury, Word Finding Difficulty,
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06848140
Recruiting
Pain Control for Cervical Ripening Balloon
for
Labor Induction
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center
Sex: Female
Age: 18+
Code: NCT07268118
Phase 2, Recruiting
Selinexor and Backbone Treatments of Multiple Myeloma Patients
for
Multiple Myeloma
Location: Boston MA, Durham NC, Seattle WA
Sponsor: Karyopharm Therapeutics Inc
Sex: All
Age: 18+
Code: NCT02343042
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
for
Mantle Cell Lymphoma, Lymphoma
Location: Boston MA, New York NY, St Louis MO
Sponsor: Christine Ryan
Sex: All
Age: 18+
Code: NCT06854003
Phase 2, Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
for
Atrial Fibrillation (AF)
Location: Boston MA, Sherbrooke, Longueuil, Montreal,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07175428
Phase 2, Recruiting
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
for
Immune Thrombocytopenia
Location: Boston MA, New Haven CT, The Bronx NY, Fairfax VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07104565
Phase 2, Recruiting
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)